CORINDUS VASCULAR ROBOTICS, INC
CVRS
CVRS was delisted on the 28th of October, 2019.
64 hedge funds and large institutions have $63.2M invested in CORINDUS VASCULAR ROBOTICS, INC in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 5 closing their positions.
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
60% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 15
10% more funds holding
Funds holding: 58 → 64 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
36% less capital invested
Capital invested by funds: $99M → $63.2M (-$35.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.45M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$499K |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
+$335K |
| 4 |
BlackRock
New York
|
+$216K |
| 5 |
State Street
Boston,
Massachusetts
|
+$201K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$6.65M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.07M |
| 3 |
Charles Schwab
San Francisco,
California
|
-$196K |
| 4 |
Goldman Sachs
New York
|
-$73.8K |
| 5 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$72K |
CVRS Hedge Fund Activity: Q4 2017 in Review
64 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in CORINDUS VASCULAR ROBOTICS, INC (CVRS) for Q4 2017, worth a combined $63.2M — down 36% from $99M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CVRS positions and 5 closed out — a net gain of 6 holders — while 24 added to existing stakes and 15 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $2.45M. The largest seller was Consonance Capital Management, cutting an estimated $6.65M.
- 64 institutional investors held CORINDUS VASCULAR ROBOTICS, INC (CVRS) as of Q4 2017, up from 58 in Q3 2017.
- Funds reported $63.2M of CORINDUS VASCULAR ROBOTICS, INC stock for Q4 2017, down 36% quarter-over-quarter.
- 11 funds opened new CORINDUS VASCULAR ROBOTICS, INC positions in Q4 2017 and 5 closed out, a net change of +6 holders.
- The largest CORINDUS VASCULAR ROBOTICS, INC buyer in Q4 2017 was Millennium Management, an estimated $2.45M added.
- The largest CORINDUS VASCULAR ROBOTICS, INC seller in Q4 2017 was Consonance Capital Management, an estimated $6.65M sold.
Based on aggregated 13F filings for Q4 2017.